Acute aspirin plus cilostazol Dual Therapy for non-cardioembolic stroke patients within 48 h of symptom onset -a prospective, multicenter, randomized, an aspirin-controlled study
Not Applicable
Recruiting
- Conditions
- on cardioembolic stroke
- Registration Number
- JPRN-UMIN000004950
- Lead Sponsor
- Stroke Medicine Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Not provided
Exclusion Criteria
cardioembolic stroke preadmission antithrombotic therapy (cilostazol, aspirin 200mg or over, clopidgrel, ticlopidine, anticoagulants) congestive heart failure pregnancy allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method modified Rakin scale score at 3 months after stroke neurological worsening within 14 days of stroke onset TIA, stroke reccurence, intracerebral hemorrhage, subarachnoid hemorrhage within 14 days of stroke onset
- Secondary Outcome Measures
Name Time Method